Valerio Therapeutics (France) Market Value
| ALVIO Stock | 0.14 0.01 6.67% |
| Symbol | Valerio |
Valerio Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Valerio Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Valerio Therapeutics.
| 01/21/2025 |
| 01/16/2026 |
If you would invest 0.00 in Valerio Therapeutics on January 21, 2025 and sell it all today you would earn a total of 0.00 from holding Valerio Therapeutics or generate 0.0% return on investment in Valerio Therapeutics over 360 days.
Valerio Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Valerio Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Valerio Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.66 | |||
| Information Ratio | 0.142 | |||
| Maximum Drawdown | 84.16 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 43.75 |
Valerio Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Valerio Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Valerio Therapeutics' standard deviation. In reality, there are many statistical measures that can use Valerio Therapeutics historical prices to predict the future Valerio Therapeutics' volatility.| Risk Adjusted Performance | 0.1129 | |||
| Jensen Alpha | 2.36 | |||
| Total Risk Alpha | 0.0755 | |||
| Sortino Ratio | 0.2272 | |||
| Treynor Ratio | (3.68) |
Valerio Therapeutics Backtested Returns
Valerio Therapeutics is out of control given 3 months investment horizon. Valerio Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.15, which indicates the firm had a 0.15 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 2.43% are justified by taking the suggested risk. Use Valerio Therapeutics Risk Adjusted Performance of 0.1129, coefficient of variation of 670.71, and Semi Deviation of 6.8 to evaluate company specific risk that cannot be diversified away. Valerio Therapeutics holds a performance score of 12 on a scale of zero to a hundred. The entity has a beta of -0.62, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Valerio Therapeutics are expected to decrease at a much lower rate. During the bear market, Valerio Therapeutics is likely to outperform the market. Use Valerio Therapeutics sortino ratio and the relationship between the downside variance and period momentum indicator , to analyze future returns on Valerio Therapeutics.
Auto-correlation | 0.03 |
Virtually no predictability
Valerio Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Valerio Therapeutics time series from 21st of January 2025 to 20th of July 2025 and 20th of July 2025 to 16th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Valerio Therapeutics price movement. The serial correlation of 0.03 indicates that only 3.0% of current Valerio Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.03 | |
| Spearman Rank Test | 0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Valerio Therapeutics lagged returns against current returns
Autocorrelation, which is Valerio Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Valerio Therapeutics' stock expected returns. We can calculate the autocorrelation of Valerio Therapeutics returns to help us make a trade decision. For example, suppose you find that Valerio Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Valerio Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Valerio Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Valerio Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Valerio Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Valerio Therapeutics Lagged Returns
When evaluating Valerio Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Valerio Therapeutics stock have on its future price. Valerio Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Valerio Therapeutics autocorrelation shows the relationship between Valerio Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Valerio Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Valerio Stock Analysis
When running Valerio Therapeutics' price analysis, check to measure Valerio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valerio Therapeutics is operating at the current time. Most of Valerio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Valerio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valerio Therapeutics' price. Additionally, you may evaluate how the addition of Valerio Therapeutics to your portfolios can decrease your overall portfolio volatility.